Quantitative Human βACE1 (Glycosylated) Sandwich ELISA Kit

The quantitative human βACE1 (glycosylated) sandwich ELISA kit is designed to detect human β-site APP cleaving enzyme 1 (βACE1) levels. BACE1 is an enzyme that plays a crucial role in the production of amyloid-beta peptides. Amyloid-beta peptides are involved in the development of Alzheimer's disease. The kit is suitable for various biological samples such as serum, plasma. Its sensitivity is 0.128 ng/mL, which can accurately detect low concentrations of βACE1 in the sample.

βACE1

Pre-coated ELISA plate; Lyophilized standard; Biotin-labeled antibody; HRP-avidin; Various diluents; Wash buffer; TMB chromogenic substrate; Stop solution

Serum, plasma

100 μL

0.128 ng/mL

Quantitative sandwich ELISA

0.55 ng/mL-15 ng/mL

1 h-5 h

450 nm

Store at 2-8°C for long term storage.

Human

β-Site APP cleaving enzyme 1

βACE1; β-Site APP cleaving enzyme 1; ASP2; Memapsin 2; Aspartyl protease 2; Membrane-associated aspartic protease 2

153, 172, 223, 354

The quantitative human βACE1 (glycosylated) sandwich ELISA kit is used to measure glycosylated BACE1 levels in samples. This measurement is important in research related to Alzheimer's disease. The kit is applied in studies of the disease process, which helps in understanding the role of BACE1.

Intra-Assay: n=20, CV <8%;
Inter-Assay: n=20, CV <10%;

Serum sample: n=5, 80-100%;
Plasma sample: n=4, 80-95%;

The standard curve is for reference only, and a new standard curve should be generated for each set of samples tested.